ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Xylem, which produces pumps, analytical instruments, and other water treatment equipment, plans to acquire Evoqua Water Technologies in a $7.5 billion all-stock transaction. The purchase will give Xylem advanced water treatment capabilities and access to customers in the life sciences, electronics, energy, and food industries. Evoqua also offers remediation for per- and polyfluoroalkyl substances. In addition, the acquisition will make industrial customers a much bigger part of Xylem’s business, which mostly serves the utility, commercial, and residential sectors. The deal is expected to close by midyear; it will give Evoqua shareholders a 25% stake in the combined company and represents a roughly 30% premium on Evoqua’s recent share price. Together, the firms are expected to have $7 billion in annual revenue. Xylem CEO Patrick Decker will continue to lead the company, and two representatives from Evoqua will join Xylem’s board. Evoqua shares jumped about 14% and Xylem shares fell about 8% after the announcement.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X